Logo

financial guidance

Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates

Twist provided fiscal second quarter revenue guidance of approximately $56.5 million, with $24 million in synbio revenues and $25 million in NGS revenues.

Roche Diagnostics Revenues Essentially Flat in 2022

Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent. 

Thermo Fisher Scientific Clinical Research Business Delivers Strong Results in First Full Year
Premium

Acquired in December 2021, PPD delivered over 20 percent of Thermo Fisher's core organic revenue growth in the fourth quarter and contributed $1.90 billion in revenue.

Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales

The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent. 

Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China

The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter. 

Jan 17, 2023

Oxford Nanopore Technologies Expects 2022 Revenue to Rise 49 Percent

Jan 9, 2023

Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance

Nov 21, 2022

Agilent Fiscal Q4 Revenues Rise 11 Percent, Full-Year 2022 Revenues Grow 8 Percent

Nov 18, 2022

Twist Bioscience Provides Update on New Factory as Fiscal Q4 Revenues Grow 51 Percent

Nov 15, 2022

Ginkgo Bioworks Raises FY 2022 Guidance as Focus on Biosecurity Intensifies

Nov 14, 2022

SomaLogic Scores One-Time, $21.2M Licensing Royalty in Q3, Raises FY 2022 Revenue Guidance

Nov 14, 2022

Sema4 Exiting Reproductive Health Screening, Cutting 500 More Jobs in Latest Restructuring

Nov 10, 2022

Olink Q3 Revenues up 59 Percent

Nov 10, 2022

Cue Health Q3 Revenues Decline 69 Percent

Nov 9, 2022

Natera Raises Guidance on Test Volume Growth, Notes Reimbursement Opportunities
Premium

Nov 8, 2022

Invitae Q3 Revenues Rise 17 Percent as Company Revises Cash Burn Guidance

Nov 8, 2022

Pacific Biosciences Announces Revio Preorders as Q3 Revenues Dip 7 Percent

Nov 8, 2022

23andMe Fiscal Q2 Revenues Grow 37 Percent as Firm Leans Into DTC Primary Care Strategy

Nov 7, 2022

Akoya Biosciences Reports 40 Percent Revenue Jump in Q3, Raises Full Year Guidance

Nov 4, 2022

Illumina Lowers FY 2022 Guidance as Q3 Revenues Rise 1 Percent

Nov 4, 2022

Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations

Nov 3, 2022

Guardant Health Sees Promising Q3 Uptake of Shield CRC Screening Test
Premium

Nov 3, 2022

Exact Sciences Q3 Revenues Rise 15 Percent

Nov 3, 2022

Bruker Posts 5 Percent Rise in Q3 Revenues

Nov 2, 2022

10x Genomics Q3 Revenues Grow 5 Percent

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.